Nobelist Paul Romer details many of the ways that the Food and Drug Administration’s (FDA) policies hampered the response to the coronavirus. This sampling belies the claim that FDA regulations save lives.
It might be time to review the massive damage that the FDA is doing by restricting the supply and use of tests for the SARS-CoV-2 virus.
Massive? With enough tests, the US could have avoided the enormous cost that this virus is imposing – at least 200,000 excess deaths and $8 trillion in lost output.
Click here to read the entire article.